Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sandhya Healthcare is a prominent Indian pharmaceutical company that specializes in the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. As a key division of the Sandhya Group, the company has established itself as a leading global supplier of anti-diabetic agents, including Metformin Hydrochloride and various sulfonylureas like Gliclazide. Their manufacturing facilities, located in Gujarat, India, are designed to meet international regulatory standards, including Good Manufacturing Practices (GMP). Sandhya Healthcare serves a diverse global clientele, providing essential components for generic drug formulations across multiple therapeutic areas. The company's focus remains on cost-effective chemical synthesis and maintaining a robust supply chain for high-volume pharmaceutical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sandhya Healthcare.